about
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009Molecular Imaging-Guided Interventional Hyperthermia in Treatment of Breast Cancer.The role of general nuclear medicine in breast cancerMonitoring of natural killer cell immunotherapy using noninvasive imaging modalities.Optical fiber-based in vivo quantification of growth factor receptors.Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors.Immunophenotyping invasive breast cancer: paving the road for molecular imagingUpregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases.Breast cancer as photodynamic therapy target: Enhanced therapeutic efficiency by overview of tumor complexityExogenous near-infrared fluorophores and their applications in cancer diagnosis: biological and clinical perspectives.Receptor conversion in distant breast cancer metastasesOestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FESSynthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.Molecular imaging probes for diagnosis and therapy evaluation of breast cancerMulti-Functionality in Theranostic Nanoparticles: is more Always Better?Near-infrared fluorescence molecular imaging of ductal carcinoma in situ with CD44v6-specific antibodies in mice: a preclinical study.Personalized medicine in oncology: tailoring the right drug to the right patient.The evolution of imaging in cancer: current state and future challenges.The use of plants for the production of therapeutic human peptides.PDGFR-β-activated ACK1-AKT signaling promotes glioma tumorigenesis.Bioluminescence imaging serves as a dynamic marker for guiding and assessing thermal treatment of cancer in a preclinical model.Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer.Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient.Synthesis and preliminary evaluation of a 18 F-labeled ethisterone derivative [18 F]EAEF for progesterone receptor targeting.
P2860
Q24657145-C5DDBF7E-0614-46FF-9229-1920E890965AQ26780500-D5A97452-44EC-445D-8E22-6CC7E6881341Q26801069-D2452310-4EDE-4245-9548-09A5F39350F4Q34049387-15F8845E-0043-4568-8203-562B23C6B740Q34226408-F6148C11-F306-4629-9629-7F34A662C8C2Q34228395-F5C19B92-5B19-4182-BC79-27801D00DD37Q34303266-9CF7D8DE-AC55-47DA-90EB-63E07A047C29Q34584209-C4B31443-2AF2-4B94-BECD-6E58F8F67F6BQ34657731-CBADC431-6D64-4C17-9504-11284B919EC5Q34954961-4B4A3DA3-FBA3-4872-80A7-2835A7B9D1C5Q34989060-2474E752-269A-4D4B-92C1-069435D84BE2Q36326057-DD143629-452B-4C18-9BDC-B23E70B5FFE9Q36555396-47755C7C-619A-41D1-B7FC-7F9561CF3CAAQ36692448-8C8F777F-F1CF-45FA-A3BE-058FB99E455FQ36737255-59BDBC76-5768-4C8F-8BCB-D2DF8953D081Q36824257-B02CFDAE-21D1-4912-9369-0CC5081CFDD8Q37779306-04613D8E-ACC5-42EE-A590-BFE6092332E7Q37848518-5F2D89AB-38CD-4B8A-BFE3-8BAC44B5A658Q37973256-6EF463B5-5980-41EB-81FF-D6CCB2208D65Q38953165-9F7CA30B-877C-4EA3-894D-EFDCFD058315Q39371077-BBBFDFFC-FE8C-4CAD-8AD5-D85552D1AC23Q42121913-73174D2B-C090-47AF-9BDB-F75321ECF486Q44585233-60AE0A08-B00A-40AE-BBDE-8B57598DFDEBQ51437587-42401C1C-7728-4CF2-A746-1372578B505E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular imaging of breast cancer.
@en
Molecular imaging of breast cancer.
@nl
type
label
Molecular imaging of breast cancer.
@en
Molecular imaging of breast cancer.
@nl
prefLabel
Molecular imaging of breast cancer.
@en
Molecular imaging of breast cancer.
@nl
P2093
P1433
P1476
Molecular imaging of breast cancer
@en
P2093
A H Brouwers
C P Schröder
E van der Wall
G A Hospers
M N Lub-de Hooge
P J van Diest
T H Oude Munnink
W B Nagengast
P304
P356
10.1016/S0960-9776(09)70276-0
P478
18 Suppl 3
P577
2009-10-01T00:00:00Z